Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
EXECUTIVE INTERVIEW - SNBL, Ltd.: Innovation in Drug Delivery Enabled Through a Unique Business Model
Drug Development Executive: Dr. Shunji Haruta, Founder of NDS (Nasal Delivery Systems) Division and Executive Officer, SNBL, Ltd., discusses how NDS Division and its powder nasal delivery platform, µco System, fit into a new paradigm.
SPECIAL REPORT - Prefilled Syringes & Parenteral Contract Manufacturing: Improving for Flexibility & Customization
Special Feature: Contributor Cindy H. Dubin speaks with prefilled syringe manufacturers as well as contract parenteral manufacturers who share their thoughts about the delivery challenges associated with high-viscous, high-volume formulations.
EXCIPIENT UPDATE - A Real Eye-Opener: Advances in Hyaluronic Acid for Ophthalmology
Hans Ole Klingenberg explains how Bacillus-derived HA offers new opportunities for ophthalmic applications by providing a safe and biocompatible source that can streamline manufacturing processes, while offering convenient application and increased patient comfort and compliance.
Foster Delivery Science Receives Grant to Develop Process for Oral Dose Drug Delivery
Foster Delivery Science recently announced it has been awarded a Manufacturer's Technical Assistance Program (MTAP) grant from the University of...RedHill Biopharma Submits NDA for Oral Thin Film Drug
RedHill Biopharma Ltd. recently announced the company and its co-development partner, IntelGenx Corp., have submitted a New Drug Application (NDA)...DELIVERY DEVICES - The New Industry Paradigm for Prefilled Success
Alan Shortall indicates that following a period of relative industry stability defined by peripheral innovation, a converging series of external and internal forces are set to reshape the prefilled syringe industry so that it will better serve the emerging needs of pharmaceutical companies, patients, and other stakeholders across the continuum of care.
3/6/2013
Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and...2/27/2012
BASF & Bend Research Sign Bioavailability Agreement BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate...BASF & Bend Research Sign Bioavailability Agreement
BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate and develop novel excipients to enhance...2/20/2013
Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of...
